These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 24987185)

  • 1. Spontaneous rectus sheath hematoma during rivaroxaban therapy.
    Kocayigit I; Can Y; Sahinkus S; Aydın E; Vatan MB; Kılıc H; Gunduz H
    Indian J Pharmacol; 2014; 46(3):339-40. PubMed ID: 24987185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rectus sheath hematoma and retroperitoneal bleeding due to rivaroxaban: a case report.
    Börekci E
    Afr Health Sci; 2019 Jun; 19(2):2290-2293. PubMed ID: 31656515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of rivaroxaban associated intracranial hemorrhage.
    Lo JC; Gerona RR
    West J Emerg Med; 2014 Jul; 15(4):375-7. PubMed ID: 25035736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rare case of losartan-induced cough complicated by rectus sheath haematoma: in a patient on rivaroxaban therapy.
    Talari G; Talari P; Sweigart J; Ahmed S
    BMJ Case Rep; 2016 Dec; 2016():. PubMed ID: 28011889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of rivaroxaban in atrial fibrillation and acute coronary syndromes.
    Reddy P; Giugliano RP
    J Cardiovasc Pharmacol Ther; 2014 Nov; 19(6):526-32. PubMed ID: 24659084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spontaneous spinal epidural haematoma during Factor Xa inhibitor treatment (Rivaroxaban).
    Jaeger M; Jeanneret B; Schaeren S
    Eur Spine J; 2012 Jun; 21 Suppl 4(Suppl 4):S433-5. PubMed ID: 21874549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rıvaroxaban-induced severe diffuse ıntracerebral hemorrhage.
    Çalışkan F; Akdemir HU; Nurata H; Akdemir N; Başara G; Yavuz Y
    Am J Emerg Med; 2015 Mar; 33(3):475.e1-5. PubMed ID: 25218622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac Tamponade Associated with Rivaroxaban.
    Boone S
    Del Med J; 2015 Jul; 87(7):206-7. PubMed ID: 26285318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New oral anticoagulants (NOAC) and liver injury.
    Moore N; Blin P; Gulmez SE
    J Hepatol; 2014 Aug; 61(2):198-9. PubMed ID: 24837361
    [No Abstract]   [Full Text] [Related]  

  • 10. Isolated hemopericardium associated with rivaroxaban: first case report.
    Shivamurthy P; Brar N; Therrien ML
    Pharmacotherapy; 2014 Sep; 34(9):e169-72. PubMed ID: 25074401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary haemorrhage from therapeutic rivaroxaban use: chest radiograph consolidation is not always infection!
    Wong A; Koutsogiannis Z; Greene SL
    Emerg Med Australas; 2014 Jun; 26(3):318-9. PubMed ID: 24809972
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy and safety of rivaroxaban compared with warfarin among elderly patients with nonvalvular atrial fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF).
    Halperin JL; Hankey GJ; Wojdyla DM; Piccini JP; Lokhnygina Y; Patel MR; Breithardt G; Singer DE; Becker RC; Hacke W; Paolini JF; Nessel CC; Mahaffey KW; Califf RM; Fox KA;
    Circulation; 2014 Jul; 130(2):138-46. PubMed ID: 24895454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rivaroxaban 2.5 mg. No justification for using this anticoagulant after an acute coronary syndrome.
    Prescrire Int; 2014 Oct; 23(153):229-32. PubMed ID: 25964962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rivaroxaban, an oral direct factor Xa inhibitor.
    Piccini JP; Patel MR; Mahaffey KW; Fox KA; Califf RM
    Expert Opin Investig Drugs; 2008 Jun; 17(6):925-37. PubMed ID: 18491993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry.
    Beyer-Westendorf J; Förster K; Pannach S; Ebertz F; Gelbricht V; Thieme C; Michalski F; Köhler C; Werth S; Sahin K; Tittl L; Hänsel U; Weiss N
    Blood; 2014 Aug; 124(6):955-62. PubMed ID: 24859362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. XANTUS: rationale and design of a noninterventional study of rivaroxaban for the prevention of stroke in patients with atrial fibrillation.
    Camm AJ; Amarenco P; Haas S; Hess S; Kirchhof P; van Eickels M; Turpie AG
    Vasc Health Risk Manag; 2014; 10():425-34. PubMed ID: 25083135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of temporary interruption of rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: results from the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation (ROCKET AF).
    Sherwood MW; Douketis JD; Patel MR; Piccini JP; Hellkamp AS; Lokhnygina Y; Spyropoulos AC; Hankey GJ; Singer DE; Nessel CC; Mahaffey KW; Fox KA; Califf RM; Becker RC;
    Circulation; 2014 May; 129(18):1850-9. PubMed ID: 24552831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of the safety of rivaroxaban versus dabigatran therapy in patients with persistent atrial fibrillation].
    Gorzelak-Pabiś P; Duraj I; Szlagowska L; Ciastkowska A; Broncel M
    Pol Merkur Lekarski; 2014 Nov; 37(221):261-4. PubMed ID: 25546985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rivaroxaban: a review of its use in the treatment of deep vein thrombosis or pulmonary embolism and the prevention of recurrent venous thromboembolism.
    Burness CB; Perry CM
    Drugs; 2014 Feb; 74(2):243-62. PubMed ID: 24430916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe drug-induced skin and liver injury from rivaroxaban.
    Barrett P; Vuppalanchi R; Masuoka H; Chalasani N
    Dig Dis Sci; 2015 Jun; 60(6):1856-8. PubMed ID: 25559757
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.